$4M Family Fundraiser Unlocks Gut-Brain NF Treatment Hope

A 25-year-old teacher's aide diagnosed with a rare genetic disorder at just four months old is finally seeing hope emerge from her family's decade-long fight to fund research. Zoe Petropoulos and her family have poured more than $4 million into neurofibromatosis research through their Flicker of Hope Foundation, and that investment just paid off in a major way.

Researchers at Melbourne's Florey Institute of Neuroscience and Mental Health discovered significant differences in the gut microbiome of mice with NF1, the genetic disorder affecting one in 2,500 Australians. The condition causes non-cancerous tumors to grow in the brain, spinal cord, and nerves, often leading to cognitive and behavioral challenges including autism and ADHD.

The personal cost to the Petropoulos family has been devastating. Zoe's sister-in-law Liz died from NF3 in 2023 at age 33, and Liz's mother, who also had NF, died weeks later.

But this new discovery could change everything for families like theirs. Lead researcher Sonali Reisinger says future therapies might be as straightforward as dietary modifications or probiotic supplements, treatments that are well-tolerated, inexpensive, and widely accessible.

Professor Anthony Hannan, who leads the research team, explains that while recent studies have explored connections between gut bacteria and brain conditions, nobody had investigated this link in NF1 until now. Their findings add crucial evidence to the growing understanding of the gut-brain connection.

The team is now working to secure funding for clinical trials to confirm whether similar gut microbiome changes occur in people with NF1, not just mice. If those trials succeed, they could unlock new treatment pathways for the cognitive and behavioral difficulties that make living with NF1 so challenging.

Why This Inspires

When Zoe told Neos Kosmos in 2021 that her family knew nothing about NF and discovered very little was known about the condition, she admitted the fear was real. She said families like hers had to put their trust in others and hope that future medical advances would bring answers.

That hope is now materializing into real science. The $4 million her foundation donated didn't just fund abstract research, it funded the specific breakthrough that could help thousands of Australian families access treatments as simple as changing what they eat or taking a probiotic.

Clinical trials are the next frontier, but researchers are optimistic that replicating these findings in humans could finally provide relief to people living with NF1-related challenges that have long gone without effective treatment options.